Edward M Zoratti1, Rebecca Z Krouse2, Denise C Babineau2, Jacqueline A Pongracic3, George T O'Connor4, Robert A Wood5, Gurjit K Khurana Hershey6, Carolyn M Kercsmar6, Rebecca S Gruchalla7, Meyer Kattan8, Stephen J Teach9, Steven M Sigelman10, Peter J Gergen10, Alkis Togias10, Cynthia M Visness2, William W Busse11, Andrew H Liu12. 1. Henry Ford Health System and Wayne State University School of Medicine, Detroit, Mich. Electronic address: ezoratt1@hfhs.org. 2. Rho Federal Systems Division, Chapel Hill, NC. 3. Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Ill. 4. Boston University School of Medicine, Boston, Mass. 5. Johns Hopkins University School of Medicine, Baltimore, Md. 6. Cincinnati Children's Hospital, Cincinnati, Ohio. 7. University of Texas Southwestern Medical Center, Dallas, Tex. 8. College of Physicians and Surgeons, Columbia University, New York, NY. 9. Children's National Health System and the George Washington University School of Medicine and Health Sciences, Washington, DC. 10. National Institutes of Allergy and Infectious Diseases, Bethesda, Md. 11. University of Wisconsin School of Medicine and Public Health, Madison, Wis. 12. National Jewish Health, Denver, Colo; Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, Colo.
Abstract
BACKGROUND: Children with asthma in low-income urban areas have high morbidity. Phenotypic analysis in these children is lacking, but may identify characteristics to inform successful tailored management approaches. OBJECTIVE: We sought to identify distinct asthma phenotypes among inner-city children receiving guidelines-based management. METHODS: Nine inner-city asthma consortium centers enrolled 717 children aged 6 to 17 years. Data were collected at baseline and prospectively every 2 months for 1 year. Participants' asthma and rhinitis were optimally managed by study physicians on the basis of guidelines. Cluster analysis using 50 baseline and 12 longitudinal variables was performed in 616 participants completing 4 or more follow-up visits. RESULTS: Five clusters (designated A through E) were distinguished by indicators of asthma and rhinitis severity, pulmonary physiology, allergy (sensitization and total serum IgE), and allergic inflammation. In comparison to other clusters, cluster A was distinguished by lower allergy/inflammation, minimally symptomatic asthma and rhinitis, and normal pulmonary physiology. Cluster B had highly symptomatic asthma despite high step-level treatment, lower allergy and inflammation, and mildly altered pulmonary physiology. Cluster C had minimally symptomatic asthma and rhinitis, intermediate allergy and inflammation, and mildly impaired pulmonary physiology. Clusters D and E exhibited progressively higher asthma and rhinitis symptoms and allergy/inflammation. Cluster E had the most symptomatic asthma while receiving high step-level treatment and had the highest total serum IgE level (median, 733 kU/L), blood eosinophil count (median, 400 cells/mm3), and allergen sensitizations (15 of 22 tested). CONCLUSIONS: Allergy distinguishes asthma phenotypes in urban children. Severe asthma often coclusters with highly allergic children. However, a symptomatic phenotype with little allergy or allergic inflammation was identified.
BACKGROUND:Children with asthma in low-income urban areas have high morbidity. Phenotypic analysis in these children is lacking, but may identify characteristics to inform successful tailored management approaches. OBJECTIVE: We sought to identify distinct asthma phenotypes among inner-city children receiving guidelines-based management. METHODS: Nine inner-city asthma consortium centers enrolled 717 children aged 6 to 17 years. Data were collected at baseline and prospectively every 2 months for 1 year. Participants' asthma and rhinitis were optimally managed by study physicians on the basis of guidelines. Cluster analysis using 50 baseline and 12 longitudinal variables was performed in 616 participants completing 4 or more follow-up visits. RESULTS: Five clusters (designated A through E) were distinguished by indicators of asthma and rhinitis severity, pulmonary physiology, allergy (sensitization and total serum IgE), and allergic inflammation. In comparison to other clusters, cluster A was distinguished by lower allergy/inflammation, minimally symptomatic asthma and rhinitis, and normal pulmonary physiology. Cluster B had highly symptomatic asthma despite high step-level treatment, lower allergy and inflammation, and mildly altered pulmonary physiology. Cluster C had minimally symptomatic asthma and rhinitis, intermediate allergy and inflammation, and mildly impaired pulmonary physiology. Clusters D and E exhibited progressively higher asthma and rhinitis symptoms and allergy/inflammation. Cluster E had the most symptomatic asthma while receiving high step-level treatment and had the highest total serum IgE level (median, 733 kU/L), blood eosinophil count (median, 400 cells/mm3), and allergen sensitizations (15 of 22 tested). CONCLUSIONS:Allergy distinguishes asthma phenotypes in urban children. Severe asthma often coclusters with highly allergic children. However, a symptomatic phenotype with little allergy or allergic inflammation was identified.
Authors: D L Rosenstreich; P Eggleston; M Kattan; D Baker; R G Slavin; P Gergen; H Mitchell; K McNiff-Mortimer; H Lynn; D Ownby; F Malveaux Journal: N Engl J Med Date: 1997-05-08 Impact factor: 91.245
Authors: Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy Journal: Am J Respir Crit Care Med Date: 2009-05-29 Impact factor: 21.405
Authors: Wei Wu; Eugene Bleecker; Wendy Moore; William W Busse; Mario Castro; Kian Fan Chung; William J Calhoun; Serpil Erzurum; Benjamin Gaston; Elliot Israel; Douglas Curran-Everett; Sally E Wenzel Journal: J Allergy Clin Immunol Date: 2014-02-28 Impact factor: 10.793
Authors: Päivi M Salo; Samuel J Arbes; Renee Jaramillo; Agustin Calatroni; Charles H Weir; Michelle L Sever; Jane A Hoppin; Kathryn M Rose; Andrew H Liu; Peter J Gergen; Herman E Mitchell; Darryl C Zeldin Journal: J Allergy Clin Immunol Date: 2014-02-09 Impact factor: 10.793
Authors: Timothy S Chang; Robert F Lemanske; David T Mauger; Anne M Fitzpatrick; Christine A Sorkness; Stanley J Szefler; Ronald E Gangnon; C David Page; Daniel J Jackson Journal: J Allergy Clin Immunol Date: 2013-10-15 Impact factor: 10.793
Authors: Mattia C F Prosperi; Umit M Sahiner; Danielle Belgrave; Cansin Sackesen; Iain E Buchan; Angela Simpson; Tolga S Yavuz; Omer Kalayci; Adnan Custovic Journal: Am J Respir Crit Care Med Date: 2013-12-01 Impact factor: 21.405
Authors: William J Sheehan; Jonathan M Gaffin; David B Peden; Robert K Bush; Wanda Phipatanakul Journal: J Allergy Clin Immunol Date: 2017-12 Impact factor: 10.793
Authors: Alkis Togias; Peter J Gergen; Jack W Hu; Denise C Babineau; Robert A Wood; Robyn T Cohen; Melanie M Makhija; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Andrew H Liu; Emily Wang; Haejin Kim; Carin I Lamm; Leonard B Bacharier; Dinesh Pillai; Steve M Sigelman; James E Gern; William W Busse Journal: J Allergy Clin Immunol Date: 2018-09-11 Impact factor: 10.793
Authors: Anna Pomés; Geoffrey A Mueller; Thomas A Randall; Martin D Chapman; L Karla Arruda Journal: Curr Allergy Asthma Rep Date: 2017-04 Impact factor: 4.806
Authors: Alan P Baptist; Wei Hao; Keerthi R Karamched; Bani Kaur; Laurie Carpenter; Peter X K Song Journal: J Allergy Clin Immunol Pract Date: 2017-07-27
Authors: Daniel J Jackson; Leonard B Bacharier; Agustin Calatroni; Michelle A Gill; Jack Hu; Andrew H Liu; Lisa M Wheatley; James E Gern; Rebecca S Gruchalla; Gurjit K Khurana Hershey; Meyer Kattan; Carolyn M Kercsmar; Haejin Kim; George T O'Connor; Shilpa Patel; Jacqueline A Pongracic; Robert A Wood; William W Busse Journal: J Allergy Clin Immunol Date: 2020-01-28 Impact factor: 10.793
Authors: Ronald L Sorkness; Edward M Zoratti; Meyer Kattan; Peter J Gergen; Michael D Evans; Cynthia M Visness; Michelle Gill; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Andrew H Liu; George T O'Connor; Jacqueline A Pongracic; Dinesh Pillai; Christine A Sorkness; Alkis Togias; Robert A Wood; William W Busse Journal: J Allergy Clin Immunol Date: 2017-11-14 Impact factor: 10.793